Viewing Study NCT00967512


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-26 @ 10:17 PM
Study NCT ID: NCT00967512
Status: WITHDRAWN
Last Update Posted: 2014-09-18
First Post: 2009-08-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course
Sponsor: Eleos, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-01
Start Date Type: None
Primary Completion Date: 2012-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2012-01
Completion Date Type: ACTUAL
First Submit Date: 2009-08-26
First Submit QC Date: None
Study First Post Date: 2009-08-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-09-16
Last Update Post Date: 2014-09-18
Last Update Post Date Type: ESTIMATED